Skip to content

Kaletra not associated with raised blood pressure, manufacturer review reports

Kaletra tablets better tolerated, patient survey finds

BHIVA: One-in-three UK HIV deaths 'not directly related to HIV'

Reduced dose of Kaletra soft-gel capsule effective in small study (corrected)

Atazanavir/efavirenz NRTI-sparing regimen effective, but raises lipid levels

Nevirapine hepatotoxicity after treatment switch no more likely at higher CD4 counts

Suspected abacavir hypersensitivity less likely to be diagnosed in people of African ethnicity

No lipid increase with Merck integrase inhibitor at 24 weeks

No fat loss with tenofovir after five years